Search This Blog

Wednesday, September 30, 2015

Lilly and Sanofi Reach Settlement Agreement in U.S. Insulin Glargine Litigation (NYSE:LLY)

Pending final FDA approval, Basaglar can be launched in the U.S. beginning on December 15, 2016



Lilly and Sanofi Reach Settlement Agreement in U.S. Insulin Glargine Litigation (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.